News | August 04, 2010

Electronic Brachytherapy Offers Safe, Convenient Alternative Option

August 4, 2010 — The ability of electronic brachytherapy to offer patients a safe, isotope-free alternative to traditional radiation therapy across a broad range of cancers was the focus of 14 clinical research studies presented at the recent American Association of Physicists in Medicine Meeting.

According to Xoft, Inc., the clinical benefits of Axxent Electronic Brachytherapy, eBx™, System for single-dose IORT and accelerated brachytherapy applications continues to be substantiated by multiple publications.

Several studies continue to demonstrate the ability of Electronic Brachytherapy to deliver equivalent treatment results to traditional isotopic therapies with reduced exposure to surrounding healthy tissues and other studies validate its safety and performance. Another series of studies explored extending the utilization of Electronic Brachytherapy with new applications to the treatment of breast and other cancers, including skin and endocavitary cancer.

Researchers from Washington University in St. Louis evaluated the ability of Electronic Brachytherapy to serve as an alternative for the treatment of early stage rectal carcinoma in the study, "A New Technique for Endocavitary Radiotherapy: Treatment with an Electronic Brachytherapy Source."

Results of the dosimetric comparison between the historically used Philips RT-50 (papillon technique) and the Xoft Axxent System were presented. Based on equivalent treatment dose and reduced exposure to treatment professionals, results demonstrated that Electronic Brachytherapy may be an excellent dosimetric replacement to the Philips RT-50 Endocavitary Unit for treatment of endocavitary cancers. With the benefits associated with the non-isotopic, electronic source, researchers concluded that this new technology may increase utilization of endocavitary radiotherapy.

The study "Comparison of Tumor and Normal Tissue Dose for Accelerated Partial Breast Irradiation Using an Electronic Brachytherapy eBx Source and Iridium-192 Source," compared treatment plans for patients treated with Electronic Brachytherapy (eBx) using the Axxent System as adjuvant therapy for early stage breast cancer with treatment plans prepared from the same CT image sets using an Iridium-192 (Ir-192) source.

Results demonstrated that both forms of balloon-based brachytherapy provide comparable dose to the planning target volume (PTV). However, Electronic Brachytherapy is associated with a considerably increased dose within the PTV near the surface of the balloon and decreased dose outside the PTV, resulting in significantly reduced dose to the heart, ipsilateral lung and healthy organs and tissue.

Related Content

Videos | Radiation Therapy | February 21, 2019
ITN Associate Editor Jeff Zagoudis speaks with Christy Kesslering, M.D., medical director of radiation oncology at th
FDA Clears Advancements for Viewray MRIdian Radiation Therapy System
Technology | Image Guided Radiation Therapy (IGRT) | February 21, 2019
February 21, 2019 — ViewRay Inc. received 510(k) clearance from the U.S.
Videos | Radiation Therapy | February 20, 2019
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., director of research and CNS neuro-oncology at the
Study Unveils Blueprint for Treating Radiation-Resistant Brain Tumor

NIH-funded researchers showed how gliomas may be treated with radiation and drugs that block DNA repair. Image courtesy of Castro lab, Michigan Medicine, Ann Arbor

 

News | Radiation Therapy | February 19, 2019
February 19, 2019 — Researchers at the University of Michigan recently searched for new brain tumor treatments by exp
Amazon Comprehend Medical Brings Medical Language Processing to Healthcare
News | Artificial Intelligence | February 15, 2019
Amazon recently announced Amazon Comprehend Medical, a new HIPAA-eligible machine learning service that allows...
Videos | Radiation Therapy | February 15, 2019
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., director of research and CNS neuro-oncology at the
New Targeted Therapy for Recurrent Brain Tumors Implanted for First Time
News | Radiation Therapy | February 15, 2019
University of Minnesota Health (M Health) is the first in the United States to begin offering GammaTile Therapy, a new...
Canon Adds Radiation Therapy Package to Aquilion Prime, Lightning CT Systems
News | Computed Tomography (CT) | February 11, 2019
In the patient-centric world of radiation oncology, it is critical that computed tomography (CT) simulation is...
Elekta Unity MR-Linac Earns FDA Clearance
Technology | Image Guided Radiation Therapy (IGRT) | February 07, 2019
The Elekta Unity magnetic resonance radiation therapy (MR/RT) system recently received 510(k) premarket notification...
University of Oklahoma Cancer Center Begins First Proton Therapy Treatments
News | Proton Therapy | February 01, 2019
Home to the largest and most comprehensive radiation therapy program in Oklahoma, the Stephenson Cancer Center at OU (...